Research Article

[Retracted] Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab

Table 3

Expression differences of inflammatory factors

GroupIL-10 (pg/mL)IL-6 (pg/L)TNF-α (ng/L)IFN-γ (ng/L)
T1T2T1T2T1T2T1T2

Scleritis group (n = 15)2.12 ± 0.913.52 ± 0.4254.62 ± 7.1942.29 ± 5.1658.82 ± 6.3145.31 ± 5.26633.44 ± 91.021001.22 ± 215.34
Nonscleral group (n = 105)2.14 ± 0.894.55 ± 0.2254.56 ± 7.1822.28 ± 5.1358.86 ± 6.2821.28 ± 5.11630.44 ± 88.211213.45 ± 294.82
t−0.081−14.7980.03014.121−0.02316.9770.123−2.683
P0.935<0.0010.976<0.0010.982<0.0010.9030.008